WallStreetZenWallStreetZen

NASDAQ: NXTC
Nextcure Inc Stock Forecast, Predictions & Price Target

Analyst price target for NXTC

Based on 2 analysts offering 12 month price targets for Nextcure Inc.
Min Forecast
$4.00+106.72%
Avg Forecast
$6.00+210.08%
Max Forecast
$8.00+313.44%

Should I buy or sell NXTC stock?

Based on 2 analysts offering ratings for Nextcure Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NXTC stock forecasts and price targets.

NXTC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-20

1 of 1

Forecast return on equity

Is NXTC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.5%

Forecast return on assets

Is NXTC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NXTC revenue forecast

What is NXTC's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.3M
Avg 2 year Forecast
$7.0M
Avg 3 year Forecast
$40.5M

NXTC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NXTC$1.94$6.00+210.08%Buy
DARE$0.55$6.00+992.90%Buy
APLM$0.61$17.00+2,709.92%Buy
CLNN$0.43$6.00+1,311.76%Strong Buy
ENTX$1.54$10.00+549.35%Buy

Nextcure Stock Forecast FAQ

Is Nextcure Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NXTC) stock is to Buy NXTC stock.

Out of 2 analysts, 0 (0%) are recommending NXTC as a Strong Buy, 2 (100%) are recommending NXTC as a Buy, 0 (0%) are recommending NXTC as a Hold, 0 (0%) are recommending NXTC as a Sell, and 0 (0%) are recommending NXTC as a Strong Sell.

If you're new to stock investing, here's how to buy Nextcure stock.

What is NXTC's revenue growth forecast for 2026-2028?

(NASDAQ: NXTC) Nextcure's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Nextcure's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NXTC's revenue for 2026 to be $92,079,989, with the lowest NXTC revenue forecast at $92,079,989, and the highest NXTC revenue forecast at $92,079,989. On average, 1 Wall Street analysts forecast NXTC's revenue for 2027 to be $195,321,189, with the lowest NXTC revenue forecast at $195,321,189, and the highest NXTC revenue forecast at $195,321,189.

In 2028, NXTC is forecast to generate $1,130,072,594 in revenue, with the lowest revenue forecast at $1,130,072,594 and the highest revenue forecast at $1,130,072,594.

What is NXTC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NXTC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NXTC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NXTC price target, the average NXTC price target is $6.00, with the highest NXTC stock price forecast at $8.00 and the lowest NXTC stock price forecast at $4.00.

On average, Wall Street analysts predict that Nextcure's share price could reach $6.00 by Mar 22, 2025. The average Nextcure stock price prediction forecasts a potential upside of 210.08% from the current NXTC share price of $1.94.

What is NXTC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NXTC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.